From: The intriguing roles of Siglec family members in the tumor microenvironment
Siglec | Protein Expression | Sialic Acid(SA) Ligands | Properties | Function | Disease | Refs |
---|---|---|---|---|---|---|
Siglec-1(CD169) | Macrophage,monocytes, mature dendritic cells | α2,3 > α2,6 | Adhesion Cell–cell interaction | Mediates antigen presentation; inhibits the proliferation of tumor-asscociated T cell; affects TAMs' function | Cancer,autoimmunity, SLE,infectious disease | |
Siglec-2(CD22) | B cells | α2,6 | Inhibition | B cell differentiation and tolerance | Lymphoma, leukemia, SLE, sepsis, RA | |
Siglec-3(CD33) | Myeloid progenitors, macrophage, monocytes, microglia | α2,6 > α2,3 | Adhesion Inhibition | Induces apoptosis; inhibits the killing effect of NK cells; regulates myeloid cell proliferation and differentiation | AML, AD | [8] |
Siglec-4(MAG) | Myelin producing cells (Oligodendrocytes, Schwann cells) | α2,3 > α2,6 | Adhesion Inhibition | Adjusts axons | Neuro-degeneration | |
Siglec-5(CD170) | Monocytes, neutrophils, B cells, activated T cells | α2,3 | Inhibition | Delivers an anti-inflammatory signal; inhibits immune cell activation | GBS infection, neutrophil disorders | |
Siglec-6(CD327) | Trophoblasts, mast cells, B cells, circulating T cells | α2,6 | Inhibition | Decrease cytotoxic functions of effector CD8 + T cells; suppress trophoblast invasivenes | Cancer, pre-eclampsia, allergy | |
Siglec-7(CD328) | NK cells, monocytes, mast cells, platelets, activated T cells | α2,8 > α2,6 > α2,3 | Binding Inhibition | Inhibits the killing effect of NK cells; inhibits inflammatory responses of mast cells and basophils | Cancer, HIV infection, allergy | |
Siglec-8 | Eosinophils, mast cells, basophils | α2,3 > α2,6 | Inhibition Apoptosis | Induces eosinophils apoptosis | Allergy, asthma | |
Siglec-9(CD329) | NK cells, monocytes, macrophages, dendritic cells, neutrophils, activated T cells | α2,3 = α2,6, or sulfated ligands | Inhibition Apoptosis | Promotes tumor angiogenesis; inhibit the proliferation and activation of TAM,NK cells and neutrophils | Cancer, asthma, sepsis, COPD, RA | |
Siglec-10 | B cells, NK cells, monocytes, CD4 + T cells | α2,3 = α2,6 | Inhibition Bind to CD24 | Induces apoptosis; inhibits the proliferation and activation of tumorassociated T cells and TAM | Cancer, sepsis, allergy | |
Siglec-11 | Macrophages, microglia | α2,8 | Inhibition | Reduced inflammatory response; inhibits microglial activation | Neuro-inflammation, AD | [24] |
Siglec-14 | Monocytes, neutrophils | α2,3 | Activation, Polymorphism | Recognizes bacterial pathogens, elicits pro-inflammatory responses | SLE, COPD, GBS infection, | |
Siglec-15 | Osteoclasts, macrophages | α2,6 or sialyl-Tn | Activation Inhibition | Modulation of osteoclast differentiation and bone resorption; immune modulation of tumorassociated T cells and TAM | Osteoporosis, cancer | |
Siglec-16 | Macrophages | α2,8 | Activation, Polymorphism | Unkown | Schizophrenia | [24] |